Antidiabetic effect of gomisin N via activation of AMP-activated protein kinase
Authors:
- 1 December 2017
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 494 (3-4) , 587-593
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Korean government (2014R1A5A2009936)
This publication has 17 references indexed in Scilit:
- AMPK: a nutrient and energy sensor that maintains energy homeostasisNature Reviews Molecular Cell Biology, 2012
- Curcumin improves insulin resistance in skeletal muscle of ratsNutrition, Metabolism and Cardiovascular Diseases, 2011
- AMPK in Health and DiseasePhysiological Reviews, 2009
- Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicineJournal of Ethnopharmacology, 2008
- Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinaseExperimental & Molecular Medicine, 2007
- Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPKBiochimica et Biophysica Acta (BBA) - General Subjects, 2006
- Type 2 diabetes: principles of pathogenesis and therapyThe Lancet, 2005
- The Antidiabetic Drug Metformin Activates the AMP-Activated Protein Kinase Cascade via an Adenine Nucleotide-Independent MechanismDiabetes, 2002
- The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling PathwaysJournal of Biological Chemistry, 2002
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001